Opus Genetics Stock Volatility
| IRD Stock | 5.03 0.19 3.93% |
Opus Genetics exhibits an elevated volatility profile over the current measurement period. The current Sharpe Ratio (Efficiency) for Opus Genetics is 0.29, indicating measured return efficiency over the last 3 months. Current risk dynamics are supported by 28 technical indicators.
Sharpe Ratio = 0.2904
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | IRD | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Opus Genetics reported a Market Risk Adjusted Performance of 66.1%, a Risk of 5.35, and a Risk Adjusted Performance of 0.2%. At about 23% of its historical trend bandwidth, Opus Genetics is operating within prior boundaries. Its impact depends on correlation and volatility interaction.
Key indicators related to Opus Genetics' volatility include:90 Days Market Risk | Chance Of Distress | 90 Days Economic Sensitivity |
Managing volatility risk for Opus Genetics positions requires understanding whether Opus Genetics' elevated volatility is driven by fundamental changes or temporary market sentiment. Fundamental-driven volatility for Opus Genetics tends to persist longer than sentiment-driven spikes.
Volatility Strategy
Opus Genetics return swings may impact long-term portfolio variance. Current statistical measures show total volatility near 5.35% with a beta coefficient of 0.0201, indicating sensitivity relative to the broader market benchmark. Risk-adjusted efficiency, represented by a Sharpe ratio of 0.29, evaluates return per unit of total risk. An alpha value of 1.33 reflects performance relative to systematic market exposure. Expected return estimates near 1.55% are derived from historical distribution modeling and help frame forward-looking return assumptions within a portfolio context. Equity volatility may reflect changes in growth expectations.
Main indicators related to Opus Genetics' market risk premium analysis include:
Beta 0.0201 | Alpha 1.33 | Risk 5.35 | Sharpe Ratio 0.29 | Expected Return 1.55 |
Moving together with Opus Stock
| 0.87 | ELTX | Elicio Therapeutics Upward Rally | PairCorr |
| 0.72 | AZN | AstraZeneca PLC | PairCorr |
| 0.85 | JNJ | Johnson Johnson | PairCorr |
| 0.71 | MRK | Merck Company | PairCorr |
| 0.82 | NVS | Novartis AG ADR | PairCorr |
| 0.79 | PFE | Pfizer Inc | PairCorr |
| 0.96 | KOP | Koppers Holdings | PairCorr |
| 0.88 | AXTI | AXT Inc Trending | PairCorr |
| 0.76 | ENBFF | Enbridge | PairCorr |
| 0.68 | HLIO | Helios Technologies | PairCorr |
| 0.68 | AIQUY | Air Liquide SA | PairCorr |
| 0.74 | TRV | The Travelers Companies | PairCorr |
| 0.74 | CAT | Caterpillar | PairCorr |
Moving against Opus Stock
| 0.91 | PBCRY | Bank Central Asia | PairCorr |
| 0.83 | PBCRF | PT Bank Central | PairCorr |
| 0.78 | BHC | Bausch Health Companies | PairCorr |
| 0.72 | NVO | Novo Nordisk AS Sell-off Trend | PairCorr |
| 0.69 | SNY | Sanofi ADR Sell-off Trend | PairCorr |
| 0.65 | TLK | Telkom Indonesia Tbk | PairCorr |
| 0.35 | TLKMF | Telkom Indonesia Tbk | PairCorr |
| 0.33 | PTBRY | Bank Negara Indonesia Normal Trading | PairCorr |
Sensitivity To Market
Opus Genetics'Opus Genetics demonstrates a beta of 0.0201, indicating market-linked volatility exposure. Regression slope interpretation supports this systematic risk estimate. Total volatility measures approximately 5.35%.Opus Genetics volatility can be described using downside deviation (4.6%), which captures negative-return intensity over the selected horizon. Options markets imply a forward-looking volatility estimate near 327.0%. This suggests the market is pricing in the possibility of wider future price swings compared to recent historical dispersion. Equity volatility often increases when trading volume rises and spreads widen in fast markets.
3 Months Beta |Analyze Opus Genetics Demand TrendCheck current 90 days Opus Genetics correlation with market (Dow Jones Industrial)Downside Risk
Opus standard deviation quantifies the magnitude of daily price swings relative to the average over the selected period. More volatile instruments exhibit higher standard deviations. This measure counts all price dispersion as risk, including returns above the mean.
Standard Deviation | 5.35 |
Standard deviation of Opus Genetics captures both favorable and adverse price swings. Downside deviation and semi-deviation focus exclusively on the adverse side of Opus Genetics' return distribution. Opus Genetics reported a Downside Deviation of 4.60, a Downside Variance of 21.12, and a Maximum Drawdown of 22.40.
Using Opus Put Option to Manage Risk Based on 2026-05-15 Contracts
Opus Genetics reported an Option Implied Volatility of 3.27 and an Option Max Pain Price of -1. A put option on Opus Genetics functions as an insurance policy for investors holding Opus Genetics' shares. It grants the holder the right to sell Opus Stock at the strike price before the expiration date.
Opus Genetics' PUT expiring on 2026-05-15
Profit |
| Opus Genetics Price At Expiration |
Current Opus Genetics Insurance Chain
| Delta | Gamma | Open Int | Expiration | Current Spread | Last Price | |||
Put | IRD260515P00002500 | -0.107583 | 0.023049 | 4 | 2026-05-15 | 0.0 - 1.05 | 0.0 | View |
Stock Volatility Analysis
Volatility is a core concept when evaluating Opus Genetics as part of a diversified portfolio. The stock's historical price swings give investors a sense of how much risk Opus Genetics' adds. Combining Opus Genetics with lower-volatility assets can reduce overall portfolio risk.
Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Opus Genetics Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
Opus Genetics Projected Return Density Against Market
Considering the 90-day investment horizon Opus Genetics has a beta of 0.0201 . This usually indicates as returns on the market go up, Opus Genetics's average returns are expected to increase less than the benchmark. However, during a bear market, the loss from holding Opus Genetics is expected to be smaller as well.Market risk ties Opus Genetics to macro cycles, whereas company or sector-specific developments represent independent drivers. Volatility metrics help measure this balance. Opus Genetics reported a Downside Deviation of 4.60, a Mean Deviation of 4.21, and an Option Implied Volatility of 3.27.
Predicted Return Density |
| Returns |
What Drives an Opus Genetics Price Volatility?
Several factors can influence a stock's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract investor attention to the company. This positive attention may impact the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Stock Risk Measures
Considering the 90-day investment horizon the coefficient of variation of Opus Genetics is 344.39. The daily returns are distributed with a variance of 28.67 and standard deviation of 5.35. The mean deviation of Opus Genetics is currently at 4.13. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.8
α | Alpha over Dow Jones | 1.33 | |
β | Beta against Dow Jones | 0.02 | |
σ | Overall volatility | 5.35 | |
Ir | Information ratio | 0.25 |
Stock Return Volatility
Opus Genetics historical daily return volatility represents how much of Opus Genetics stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The firm has volatility of 5.3545% on return distribution over a 90-day investment horizon. By contrast, Dow Jones Industrial accepts 0.792% volatility on return distribution over a 90-day horizon. Performance |
| Timeline |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Opus Stock performing well and Opus Genetics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Opus Genetics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ABOS | 3.85 | 0.93 | 0.25 | -12.12 | 3.22 | 9.18 | 38.93 | |||
| SEER | 1.94 | 0.04 | 0.02 | 0.01 | 3.22 | 4.05 | 25.22 | |||
| AGEN | 3.67 | -0.21 | 0.00 | -0.20 | 0.00 | 6.98 | 30.06 | |||
| INO | 3.20 | -0.22 | 0.00 | -0.66 | 0.00 | 5.23 | 36.52 | |||
| VTGN | 4.97 | -1.55 | 0.00 | -1.41 | 0.00 | 6.06 | 87.87 | |||
| HURA | 7.23 | 0.84 | 0.08 | 0.17 | 8.11 | 20.00 | 75.53 | |||
| ALEC | 3.25 | 1.08 | 0.28 | 0.41 | 2.92 | 8.68 | 21.36 | |||
| CGTX | 3.61 | -0.61 | 0.00 | -0.43 | 0.00 | 6.00 | 20.99 | |||
| TIL | 3.00 | 0.00 | 0.00 | -0.04 | 0.00 | 6.98 | 54.86 | |||
| MCRB | 3.31 | -0.72 | 0.00 | -0.37 | 0.00 | 4.80 | 46.80 |
Risk Metrics, Assumptions & Methodology
Volatility for Opus Genetics measures return dispersion and uncertainty over time. Uncertainty impacts position sizing assumptions in portfolio models. Opus Genetics has a market cap of 333.79 M, ROE of -2.42%.
Macroaxis compiles Opus Genetics metrics from periodic company reporting and market reference feeds and applies consistent transformation rules before display. Analyst inputs may be included when coverage is available. Not all fields update in real time. Volatility and downside metrics are estimated from historical return dispersion.
This content is curated and reviewed by:
Michael Smolkin - Member of Macroaxis Board of DirectorsOpus Genetics Investment Opportunity
Measured over the selected horizon, Opus Genetics carries roughly 6.77 times the return volatility of Dow Jones Industrial. That added volatility may be acceptable only if the position is expected to deliver stronger return efficiency or diversification value.You can use Opus Genetics to enhance the returns of your portfolios. This move summary looks at how the current session may translate into a basic near-term setup. It gives extra weight to the size of the move, the quote level, and whether the instrument trades in a hype-prone venue. an unexpected upward trend. Watch out for market signals. Check odds of Opus Genetics to be traded at 6.04 in 90 days.Very good diversification
Across the chosen horizon, IRD and DJI show a correlation of -0.25 and fall into the Very good diversification bucket. In portfolio terms, the overlap visualization shows how much shared movement remains after both positions are combined.
Opus Genetics Additional Risk Indicators
Risk analysis around Opus Genetics becomes more useful when investors review secondary indicators that can confirm, refine, or challenge the basic volatility picture. Used correctly, these measures can support both standalone risk assessment and portfolio-level hedging decisions.
| Risk Adjusted Performance | 0.2054 | |||
| Market Risk Adjusted Performance | 66.14 | |||
| Mean Deviation | 4.21 | |||
| Semi Deviation | 3.88 | |||
| Downside Deviation | 4.6 | |||
| Coefficient Of Variation | 403.83 | |||
| Standard Deviation | 5.41 |
Opus Genetics Suggested Diversification Pairs
Pair trading with Opus Genetics can help investors hedge some company-specific exposure by balancing a long view with an offsetting position. The key question is whether the second leg adds real hedge value instead of just creating a more complex version of the same risk.
| Alphabet vs. Opus Genetics | ||
| Dupont De vs. Opus Genetics | ||
| Citigroup vs. Opus Genetics | ||
| Microsoft vs. Opus Genetics | ||
| Salesforce vs. Opus Genetics | ||
| Walker Dunlop vs. Opus Genetics | ||
| GM vs. Opus Genetics | ||
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Opus Genetics as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Opus Genetics' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Opus Genetics' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Opus Genetics.
Popular Tools for Opus Stock analysis
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Stocks Directory Find actively traded stocks across global markets | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Global Correlations Find global opportunities by holding instruments from different markets |